3288 results for «2026年2月卫星ETF资金流出原因»
3288 results
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
The ARC consensus on DCB - evidence-based DCB technology
15 May 2024 – From EuroPCR 2024
In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
Abstracts from the Call for submissions - Nurses and Allied Professionals
16 May 2024 – From EuroPCR 2024
This session features selected abstracts from the call for submissions, focusing on the contributions of nurses and allied health professionals in the field of interventional cardiology. The presentations cover topics such as patient experience in the TAVI process, insights into the use of intravascular imaging and...
When imaging guides PCI complications management
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions highlighting the role of imaging in managing complications during percutaneous coronary interventions (PCI). Experts will present and discuss cases involving recurrent acute myocardial infarction, stent crumpling, and other unexpected complications, demonstrating how the use of various imaging...
ANOCA/INOCA: when angiography is not enough to reach a diagnosis
16 May 2024 – From EuroPCR 2024
This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...
MitraClip Asian experience: clinical evidence and experience in challenging anatomies
15 May 2024 – From EuroPCR 2024
Watch this session to gain insights into the clinical evidence of mitral TEER therapy for the Asian population, learn techniques for implanting a MitraClip in patients with challenging anatomy, and understand how to use the four clip sizes for optimal outcomes. The session also covers educational...
Evolution of complex PCI: cross, modify it, and be precise!
14 May 2024 – From EuroPCR 2024
Don't miss this session for expert guidance on preparing and managing complex lesions. Gain insights into choosing the right tools, including microcatheters and balloons, for optimal treatment outcomes. Explore the innovative features of flagship devices for complex PCI, and Pronavi microcatheter and Alveo HP CTO balloon...
Supraflex Cruz - Improving patient outcomes: from simple to complex patients
14 May 2024 – From EuroPCR 2024
Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
15 May 2024 – From EuroPCR 2024
Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...
Case closed: understanding the steps of vascular access and closure in TAVI patients
14 May 2024 – From EuroPCR 2024
Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...
Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy
In this session featuring a LIVE case demonstration from Madrid, Spain, gain insights into identifying calcified lesions requiring plaque modification, effectively guiding lesion treatment with OCT support, and correctly applying orbital atherectomy, while sharing experiential knowledge step by step.
Contemporary TAVI: the VISION of lifetime management
15 May 2024 – From EuroPCR 2024
In this session, discover how pre-procedural assessment is used to optimize procedural outcomes, ensuring the best possible results for patients undergoing TAVI, learn the intricacies of selecting the most suitable valve for each individual patient, considering their unique anatomical and clinical factors, and engage in discussions...
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
The complexity in treatment of patients in shock
16 May 2024 – From EuroPCR 2024
This session is essential for those looking to analyze and discuss the findings of the DanGer shock randomized trial, explore the latest evidence in the ACS field such as Horizon, and implement evidence-based practices in peri-procedural planning, execution, drug administration, and weaning strategies to optimize outcomes...
Mastering the future of PCI with drug-coated balloons
16 May 2024 – From EuroPCR 2024
Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...
Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes
14 May 2024 – From EuroPCR 2024
Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...
A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence
15 May 2024 – From EuroPCR 2024
In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...
Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI
15 May 2024 – From EuroPCR 2024
Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...
Second generation biolimus drug-coated balloon in clinical practice
15 May 2024 – From EuroPCR 2024
Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...
